OKLAHOMA CITY, OK — Lawmakers in the Oklahoma House have approved a proposal to expand the conditions that qualify for the state’s limited cannabidiol-only medical cannabis law.
The bill would allow the same patient protections currently available to those with intractable forms of pediatric epilepsy to those suffering from Alzheimer’s disease, dementia, chronic pain, neuropathic pain, spasticity due to multiple sclerosis or due to paraplegia, intractable nausea and vomiting, appetite stimulation with chronic wasting diseases, and/or attention deficit hyperactivity disorder or bipolar affective disorder.
Under a law passed last year, patients with intractable forms of pediatric epilepsy are exempt from criminal penalties if they are caught possessing liquid cannabidiol (CBD) products under a physician’s authorization.
These cannabis-based medications can not contain any more than .3% tetrahydrocannabinol (THC). In-state cultivation and production of these products are not authorized under current law, however.
Full text of the bill, which now heads to the Senate, can be found here.
© 2016 The Daily Chronic. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without expressed, written permission.
Thank you for visiting MDMMCC.com, the premier Medical Marijuana Certification Center in Maryland. Our Mission at the Maryland Medical Marijuana Certification Clinics (MDMMCC) is to provide the certification necessary for qualified patients to obtain Medical Marijuana in compliance with the Maryland Medical Marijuana Laws in the State of Maryland. MDMMCC will have offices open throughout Maryland.